IV期非小细胞肺癌腺癌中转移模式与分子状态的关联
该回顾性研究纳入2010年1月至2017年5月550例IV期肺腺癌患者,分析驱动基因改变与影像转移部位的关联。与4N组相比,EGFR突变组胸膜转移更多而肾上腺和淋巴结转移更少,ALK重排组脑和肺转移更多,BRAF突变组胸膜和心包转移更多而骨转移更少。作者认为这些关联可能有助于更早识别适合靶向治疗的患者。
要点
- 骨和脑是肺腺癌最常见转移部位,但各转移部位相对发生率取决于分子改变类型。
- EGFR突变肿瘤倾向胸膜转移,肾上腺和淋巴结转移较少见。
- ALK重排肿瘤常转移至脑和肺,BRAF突变肿瘤少转移至骨而倾向浆膜(胸膜和心包)转移。
关键影像表现/征象
- 与4N组相比,EGFR组胸膜转移更频繁(32% vs 20%,p=0.021),肾上腺转移(6% vs 23%,p<0.001)和淋巴结转移(11% vs 23%,p=0.011)更少见。
- 与4N组相比,ALK组脑转移(42% vs 29%,p=0.043)和肺转移(37% vs 24%,p=0.037)更多。
- 与4N组相比,BRAF组胸膜转移(47% vs 20%,p<0.001)和心包转移(11% vs 3%,p=0.04)更常见,骨转移更少(21% vs 42%,p=0.011)。
- 淋巴管炎在EGFR、ALK和BRAF组更频繁(分别为6%、7%、15% vs 1%;p=0.016、p=0.009、p<0.001)。
临床应用与阅片要点
- 作者认为,将分子状态与转移倾向的关联应用于临床,可能有助于更早、更准确识别适合靶向治疗的患者。
- 骨和脑是肺腺癌最常见转移器官,但各转移部位相对发生率取决于分子改变类型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of our study was to investigate the association between driver oncogene alterations and metastatic patterns on imaging assessment, in a large cohort of metastatic lung adenocarcinoma patients.
METHODS: From January 2010 to May 2017, 550 patients with stage IV lung adenocarcinoma with molecular analysis were studied retrospectively including 135 EGFR-mutated, 81 ALK-rearrangement, 47 BRAF-mutated, 141 KRAS-mutated, and 146 negative tumors for these 4 mutations (4N). After review of the complete imaging report by two radiologists (junior and senior) to identify metastatic sites, univariate correlation analyzes were performed.
RESULTS: We found differences in metastatic tropism depending on the molecular alteration type when compared with the non-mutated 4N group: in the EGFR group, pleural metastases were more frequent (32% versus 20%; p = 0.021), and adrenal and node metastases less common (6% versus 23%; p < 0.001 and 11% versus 23%; p = 0.011). In the ALK group, there were more brain and lung metastases (respectively 42% versus 29%; p = 0.043 and 37% versus 24%; p = 0.037). In the BRAF group, pleural and pericardial metastases were more common (respectively 47% versus 20%; p < 0.001 and 11% versus 3%; p = 0.04) and bone metastases were rarer (21% versus 42%; p = 0.011). Lymphangitis was more frequent in EGFR, ALK, and BRAF groups (respectively 6%, 7%, and 15% versus 1%); p = 0.016; p = 0.009; and p < 0.001.
CONCLUSION: The application of these correlations between molecular status and metastatic tropism in clinical practice may lead to earlier and more accurate identification of patients for targeted therapy.
KEY POINTS: • Bone and brain metastasis are the most common organs involved in lung adenocarcinoma but the relative incidence of each metastatic site depends on the molecular alteration. • EGFR-mutated tumors preferentially spread to the pleura and less commonly to adrenals, ALK-rearrangement tumors usually spread to the brain and the lungs, whereas BRAF-mutated tumors are unlikely to spread to bones and have a serous (pericardial ad pleural) tropism. • These correlations could help in the clinical management of patients with metastatic lung adenocarcinoma.
引用
- Dormieux A, Mezquita L, Cournede PH, et al. Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma. Eur Radiol. 2020. PMID: 32323012. doi:10.1007/s00330-020-06784-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。